These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29208719)

  • 21. Ultrasound Improves the Delivery and Therapeutic Effect of Nanoparticle-Stabilized Microbubbles in Breast Cancer Xenografts.
    Snipstad S; Berg S; Mørch Ý; Bjørkøy A; Sulheim E; Hansen R; Grimstad I; van Wamel A; Maaland AF; Torp SH; Davies CL
    Ultrasound Med Biol; 2017 Nov; 43(11):2651-2669. PubMed ID: 28781149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patented nanomedicines for the treatment of brain tumors.
    Caruso G; Raudino G; Caffo M
    Pharm Pat Anal; 2013 Nov; 2(6):745-54. PubMed ID: 24237240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-Assembly of Gold Nanoparticles Shows Microenvironment-Mediated Dynamic Switching and Enhanced Brain Tumor Targeting.
    Feng Q; Shen Y; Fu Y; Muroski ME; Zhang P; Wang Q; Xu C; Lesniak MS; Li G; Cheng Y
    Theranostics; 2017; 7(7):1875-1889. PubMed ID: 28638474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Addressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery.
    Yang Q; Parker CL; McCallen JD; Lai SK
    J Control Release; 2015 Dec; 220(Pt B):715-26. PubMed ID: 26407672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics.
    Overchuk M; Zheng G
    Biomaterials; 2018 Feb; 156():217-237. PubMed ID: 29207323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanomedicines Targeting the Tumor Microenvironment.
    Tong R; Langer R
    Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mitochondria-targeting gold-peptide nanoassembly for enhanced cancer-cell killing.
    Ma X; Wang X; Zhou M; Fei H
    Adv Healthc Mater; 2013 Dec; 2(12):1638-43. PubMed ID: 23657942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperthermia approaches for enhanced delivery of nanomedicines to solid tumors.
    Frazier N; Ghandehari H
    Biotechnol Bioeng; 2015 Oct; 112(10):1967-83. PubMed ID: 25995079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gold nanoparticle delivery to solid tumors: a multiparametric study on particle size and the tumor microenvironment.
    Izci M; Maksoudian C; Gonçalves F; Aversa L; Salembier R; Sargsian A; Pérez Gilabert I; Chu T; Rios Luci C; Bolea-Fernandez E; Nittner D; Vanhaecke F; Manshian BB; Soenen SJ
    J Nanobiotechnology; 2022 Dec; 20(1):518. PubMed ID: 36494816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical oncology: New targets for nanomedicine.
    Nicolas-Boluda A; Silva AKA; Fournel S; Gazeau F
    Biomaterials; 2018 Jan; 150():87-99. PubMed ID: 29035739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved Targeting of Cancers with Nanotherapeutics.
    Foster C; Watson A; Kaplinsky J; Kamaly N
    Methods Mol Biol; 2017; 1530():13-37. PubMed ID: 28150194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophages as Active Nanocarriers for Targeted Early and Adjuvant Cancer Chemotherapy.
    Si J; Shao S; Shen Y; Wang K
    Small; 2016 Oct; 12(37):5108-5119. PubMed ID: 27560388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mathematical modeling of the heterogeneous distributions of nanomedicines in solid tumors.
    He H; Liu C; Liu Y; Liu X; Wu Y; Fan J; Zhao L; Cao Y
    Eur J Pharm Biopharm; 2019 Sep; 142():153-164. PubMed ID: 31226367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoparticle-based drug delivery in cancer: the role of cell membrane structures.
    Yalçın S; Özlüer Ö; Gündüz U
    Ther Deliv; 2016 Nov; 7(11):773-781. PubMed ID: 27790949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Precisely Regulated Luminescent Gold Nanoparticles for Identification of Cancer Metastases.
    Tan Y; He K; Tang B; Chen H; Zhao Z; Zhang C; Lin L; Liu J
    ACS Nano; 2020 Oct; 14(10):13975-13985. PubMed ID: 32865989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Size-dependent tissue kinetics of PEG-coated gold nanoparticles.
    Cho WS; Cho M; Jeong J; Choi M; Han BS; Shin HS; Hong J; Chung BH; Jeong J; Cho MH
    Toxicol Appl Pharmacol; 2010 May; 245(1):116-23. PubMed ID: 20193702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting tumor associated macrophages: The new challenge for nanomedicine.
    Andón FT; Digifico E; Maeda A; Erreni M; Mantovani A; Alonso MJ; Allavena P
    Semin Immunol; 2017 Dec; 34():103-113. PubMed ID: 28941641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor priming enhances delivery and efficacy of nanomedicines.
    Lu D; Wientjes MG; Lu Z; Au JL
    J Pharmacol Exp Ther; 2007 Jul; 322(1):80-8. PubMed ID: 17420296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.